世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

DNA合成-世界市場シェアとランキング、全体売上高と需要予測 2024-2030


DNA Synthesis- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

DNA合成の世界市場は、2023年に12億2053万米ドルと推定され、2024年から2030年の予測期間中に14.04%のCAGRで、2030年までに3億1200万米ドルの再調整された規模になると予測されている。 DNA合成の北米市場は、2... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2024年4月2日 US$3,950
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

DNA合成の世界市場は、2023年に12億2053万米ドルと推定され、2024年から2030年の予測期間中に14.04%のCAGRで、2030年までに3億1200万米ドルの再調整された規模になると予測されている。
DNA合成の北米市場は、2023年に4億2280万ドルと評価され、2024年から2030年の予測期間中に11.42%のCAGRで、2030年までに8億8700万ドルに達すると予測される。
DNA合成のアジア太平洋市場は、2023年に4億4378万ドルと評価され、2024年から2030年の予測期間中に17.2%のCAGRで、2030年までに1億33200万ドルに達する。
DNA合成のヨーロッパ市場は、2023年に3億1,180万ドルと評価され、2024年から2030年の予測期間中に12.2%のCAGRで、2030年までに6億8,600万ドルに達する。

DNA合成の世界の主要企業は、Genescript、Thermo Fisher Scientific、IDT、Twist Bioscience、BBI、Eurofins Genomics、DNA 2.0(ATUM)、OriGene、Eurogentecなどである。2023年、世界の大手5社の売上高シェアは約53.36%である。
本レポートは、DNA合成の世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総売上高、主要企業の市場シェア、ランキングを中心に包括的に紹介することを目的としています。
DNA合成の市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データを売上高(百万ドル)で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、DNA合成に関する十分な情報に基づいたビジネス上の意思決定を行えるよう支援します。

市場区分
企業別
ジェネスクリプト
サーモフィッシャーサイエンティフィック
IDT
ユーロフィンズ・ゲノミクス
DNA 2.0 (ATUM)
BBI
アゼンタ・ライフサイエンス
SBSジェネテック
バイオベーシック
ツイストバイオサイエンス
オリジーン
ビオネア
イートン・バイオサイエンス
シンバイオ・テクノロジー
ユーロジェンテック

タイプ別セグメント
オリゴヌクレオチド合成
遺伝子合成

用途別セグメント
商業
学術研究

地域別
北米
アメリカ
カナダ
メキシコ

アジア太平洋
中国
日本
韓国
東南アジア
インド
その他のアジア太平洋地域

欧州
ドイツ
フランス
英国
イタリア
ロシア
その他のヨーロッパ

南米
ブラジル
その他の南米諸国

中東・アフリカ
中東
アフリカ


各章の概要
第1章:報告書のスコープ、世界の総市場規模を紹介します。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析などを提供します。
第2章:DNA合成企業の競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。
第3章:各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模と発展可能性を網羅し、読者が各市場セグメントのブルーオーシャン市場を見つけるのに役立つ。
第4章:用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性を網羅し、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第5章:地域レベルでのDNA合成の収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展見込み、市場空間、市場規模を紹介する。
第6章 DNA合成の国別収益。各国・地域のタイプ別、用途別のシグメイトデータを提供。
第7章:主要企業のプロファイルを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。
第8章:産業の上流と下流を含む産業チェーンの分析。
第9章:結論

ページTOPに戻る


目次

1 Market Overview 1
1.1 DNA Synthesis Product Introduction 1
1.2 Global DNA Synthesis Market Size Forecast (2019-2030) 1
1.3 DNA Synthesis Market Trends & Drivers 3
1.3.1 DNA Synthesis Industry Trends 3
1.3.2 DNA Synthesis Market Drivers & Opportunity 5
1.3.3 DNA Synthesis Market Challenges 6
1.3.4 DNA Synthesis Market Restraints 7
1.4 Assumptions and Limitations 7
1.5 Study Objectives 8
1.6 Years Considered 9
2 Competitive Analysis by Company 10
2.1 Global DNA Synthesis Players Revenue Ranking (2023) 10
2.2 Global DNA Synthesis Revenue by Company (2019-2024) 11
2.3 Key Companies DNA Synthesis Area Served and Headquarters 12
2.4 Key Companies DNA Synthesis Product Offered 13
2.5 Key Companies Time to Begin Mass Production of DNA Synthesis 14
2.6 DNA Synthesis Market Competitive Analysis 15
2.6.1 DNA Synthesis Market Concentration Rate (2019-2024) 15
2.6.2 Global 5 and 10 Largest Companies by DNA Synthesis Revenue in 2023 16
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Synthesis as of 2023) 17
2.7 Mergers & Acquisitions, Expansion 18
3 Segmentation by Type 21
3.1 Introduction by Type 21
3.1.1 Oligonucleotide Synthesis 21
3.1.2 Gene Synthesis 22
3.2 Global DNA Synthesis Sales Value by Type 22
3.2.1 Global DNA Synthesis Sales Value by Type (2019 VS 2023 VS 2030) 23
3.2.2 Global DNA Synthesis Sales Value, by Type (2019-2030) 24
3.2.3 Global DNA Synthesis Sales Value, by Type (%) (2019-2030) 25
4 Segmentation by Application 26
4.1 Introduction by Application 26
4.1.1 Commercial 26
4.1.2 Academic Research 26
4.2 Global DNA Synthesis Sales Value by Application 27
4.2.1 Global DNA Synthesis Sales Value by Application (2019 VS 2023 VS 2030) 28
4.2.2 Global DNA Synthesis Sales Value, by Application (2019-2030) 29
4.2.3 Global DNA Synthesis Sales Value, by Application (%) (2019-2030) 30
5 Segmentation by Region 31
5.1 Global DNA Synthesis Sales Value by Region 31
5.1.1 Global DNA Synthesis Sales Value by Region: 2019 VS 2023 VS 2030 31
5.1.2 Global DNA Synthesis Sales Value by Region (2019-2024) 31
5.1.3 Global DNA Synthesis Sales Value by Region (2025-2030) 32
5.1.4 Global DNA Synthesis Sales Value by Region (%), (2019-2030) 32
5.2 North America 33
5.2.1 North America DNA Synthesis Sales Value, 2019-2030 33
5.2.2 North America DNA Synthesis Sales Value by Country (%), 2023 VS 2030 34
5.3 Europe 35
5.3.1 Europe DNA Synthesis Sales Value, 2019-2030 35
5.3.2 Europe DNA Synthesis Sales Value by Country (%), 2023 VS 2030 36
5.4 Asia Pacific 37
5.4.1 Asia Pacific DNA Synthesis Sales Value, 2019-2030 37
5.4.2 Asia Pacific DNA Synthesis Sales Value by Region (%), 2023 VS 2030 38
5.5 South America 39
5.5.1 South America DNA Synthesis Sales Value, 2019-2030 39
5.5.2 South America DNA Synthesis Sales Value by Country (%), 2023 VS 2030 40
5.6 Middle East & Africa 41
5.6.1 Middle East & Africa DNA Synthesis Sales Value, 2019-2030 41
5.6.2 Middle East & Africa DNA Synthesis Sales Value by Country (%), 2023 VS 2030 42
6 Segmentation by Key Countries/Regions 43
6.1 Key Countries/Regions DNA Synthesis Sales Value Growth Trends, 2019 VS 2023 VS 2030 43
6.2 Key Countries/Regions DNA Synthesis Sales Value, 2019-2030 44
6.3 North America 47
6.3.1 North America DNA Synthesis Sales Value, 2019-2030 47
6.3.2 North America DNA Synthesis Sales Value by Type (%), 2023 VS 2030 48
6.3.3 North America DNA Synthesis Sales Value by Application, 2023 VS 2030 48
6.4 Europe 49
6.4.1 Europe DNA Synthesis Sales Value, 2019-2030 49
6.4.2 Europe DNA Synthesis Sales Value by Type (%), 2023 VS 2030 50
6.4.3 Europe DNA Synthesis Sales Value by Application, 2023 VS 2030 50
6.5 Asia-Pacific 51
6.5.1 Asia-Pacific DNA Synthesis Sales Value, 2019-2030 51
6.5.2 Asia-Pacific DNA Synthesis Sales Value by Type (%), 2023 VS 2030 52
6.5.3 Asia-Pacific DNA Synthesis Sales Value by Application, 2023 VS 2030 52
6.6 South America 53
6.6.1 South America DNA Synthesis Sales Value, 2019-2030 53
6.6.2 South America DNA Synthesis Sales Value by Type (%), 2023 VS 2030 54
6.6.3 South America DNA Synthesis Sales Value by Application, 2023 VS 2030 54
6.7 Middle East and Africa 55
6.7.1 Middle East and Africa DNA Synthesis Sales Value, 2019-2030 55
6.7.2 Middle East and Africa DNA Synthesis Sales Value by Type (%), 2023 VS 2030 56
6.7.3 Middle East and Africa DNA Synthesis Sales Value by Application, 2023 VS 2030 56
7 Company Profiles 57
7.1 GenScript Biotech 57
7.1.1 GenScript Biotech Profile 57
7.1.2 GenScript Biotech Main Business 58
7.1.3 GenScript Biotech DNA Synthesis Products, Services and Solutions 58
7.1.4 GenScript Biotech DNA Synthesis Revenue (US$ Million) & (2019-2024) 60
7.1.5 GenScript Biotech Recent Developments 60
7.2 Thermo Fisher Scientific 61
7.2.1 Thermo Fisher Scientific Profile 61
7.2.2 Thermo Fisher Scientific Main Business 62
7.2.3 Thermo Fisher Scientific DNA Synthesis Products, Services and Solutions 62
7.2.4 Thermo Fisher Scientific DNA Synthesis Revenue (US$ Million) & (2019-2024) 64
7.2.5 Thermo Fisher Scientific Recent Developments 64
7.3 IDT 65
7.3.1 IDT Profile 65
7.3.2 IDT Main Business 66
7.3.3 IDT DNA Synthesis Products, Services and Solutions 67
7.3.4 IDT DNA Synthesis Revenue (US$ Million) & (2019-2024) 67
7.3.5 IDT Recent Developments 68
7.4 Eurofins Scientific 69
7.4.1 Eurofins Scientific Profile 69
7.4.2 Eurofins Scientific Main Business 70
7.4.3 Eurofins Scientific DNA Synthesis Products, Services and Solutions 70
7.4.4 Eurofins Scientific DNA Synthesis Revenue (US$ Million) & (2019-2024) 72
7.4.5 Eurofins Scientific Recent Developments 73
7.5 DNA 2.0 (ATUM) 73
7.5.1 DNA 2.0 (ATUM) Profile 73
7.5.2 DNA 2.0 (ATUM) Main Business 74
7.5.3 DNA 2.0 (ATUM) DNA Synthesis Products, Services and Solutions 74
7.5.4 DNA 2.0 (ATUM) DNA Synthesis Revenue (US$ Million) & (2019-2024) 75
7.6 BBI 76
7.6.1 BBI Profile 76
7.6.2 BBI Main Business 76
7.6.3 BBI DNA Synthesis Products, Services and Solutions 77
7.6.4 BBI DNA Synthesis Revenue (US$ Million) & (2019-2024) 78
7.6.5 BBI Recent Developments 79
7.7 Azenta Life Sciences 79
7.7.1 Azenta Life Sciences Profile 79
7.7.2 Azenta Life Sciences Main Business 80
7.7.3 Azenta Life Sciences DNA Synthesis Products, Services and Solutions 81
7.7.4 Azenta Life Sciences DNA Synthesis Revenue (US$ Million) & (2019-2024) 82
7.7.5 Azenta Life Sciences Recent Developments 82
7.8 SBS Genetech 83
7.8.1 SBS Genetech Profile 83
7.8.2 SBS Genetech Main Business 84
7.8.3 SBS Genetech DNA Synthesis Products, Services and Solutions 85
7.8.4 SBS Genetech DNA Synthesis Revenue (US$ Million) & (2019-2024) 86
7.9 Bio Basic 86
7.9.1 Bio Basic Profile 86
7.9.2 Bio Basic Main Business 87
7.9.3 Bio Basic DNA Synthesis Products, Services and Solutions 87
7.9.4 Bio Basic DNA Synthesis Revenue (US$ Million) & (2019-2024) 88
7.10 Twist Bioscience 88
7.10.1 Twist Bioscience Profile 88
7.10.2 Twist Bioscience Main Business 89
7.10.3 Twist Bioscience DNA Synthesis Products, Services and Solutions 89
7.10.4 Twist Bioscience DNA Synthesis Revenue (US$ Million) & (2019-2024) 90
7.10.5 Twist Bioscience Recent Developments 90
7.11 OriGene 91
7.11.1 OriGene Profile 91
7.11.2 OriGene Main Business 92
7.11.3 OriGene DNA Synthesis Products, Services and Solutions 93
7.11.4 OriGene DNA Synthesis Revenue (US$ Million) & (2019-2024) 93
7.12 Bioneer 93
7.12.1 Bioneer Profile 93
7.12.2 Bioneer Main Business 94
7.12.3 Bioneer DNA Synthesis Products, Services and Solutions 95
7.12.4 Bioneer DNA Synthesis Revenue (US$ Million) & (2019-2024) 95
7.13 Eton Bioscience 96
7.13.1 Eton Bioscience Profile 96
7.13.2 Eton Bioscience Main Business 96
7.13.3 Eton Bioscience DNA Synthesis Products, Services and Solutions 97
7.13.4 Eton Bioscience DNA Synthesis Revenue (US$ Million) & (2019-2024) 98
7.14 Synbio Technologies 98
7.14.1 Synbio Technologies Profile 98
7.14.2 Synbio Technologies Main Business 99
7.14.3 Synbio Technologies DNA Synthesis Products, Services and Solutions 100
7.14.4 Synbio Technologies DNA Synthesis Revenue (US$ Million) & (2019-2024) 100
7.15 Eurogentec 101
7.15.1 Eurogentec Profile 101
7.15.2 Eurogentec Main Business 101
7.15.3 Eurogentec DNA Synthesis Products, Services and Solutions 102
7.15.4 Eurogentec DNA Synthesis Revenue (US$ Million) & (2019-2024) 103
8 Industry Chain Analysis 104
8.1 DNA Synthesis Industrial Chain 104
8.2 DNA Synthesis Upstream Analysis 105
8.2.1 Key Raw Materials 105
8.2.2 Raw Materials Key Suppliers 105
8.2.3 Manufacturing Cost Structure 106
8.3 Downstream Analysis (Customers Analysis) 107
8.4 Sales Model and Sales Channels 109
8.4.1 DNA Synthesis Sales Model 109
8.4.2 Sales Channel 109
8.4.3 DNA Synthesis Distributors 110
9 Research Findings and Conclusion 113
10 Appendix 115
10.1 Research Methodology 115
10.1.1 Methodology/Research Approach 115
10.1.2 Data Source 118
10.2 Author Details 121
10.3 Disclaimer 121


 

ページTOPに戻る


 

Summary

The global market for DNA Synthesis was estimated to be worth US$ 1,220.53 million in 2023 and is forecast to a readjusted size of US$ 3012 million by 2030 with a CAGR of 14.04% during the forecast period 2024-2030.
North American market for DNA Synthesis was valued at $ 422.8 million in 2023 and will reach $ 887 million by 2030, at a CAGR of 11.42% during the forecast period of 2024 through 2030.
Asia-Pacific market for DNA Synthesis was valued at $ 443.78 million in 2023 and will reach $ 1332 million by 2030, at a CAGR of 17.2% during the forecast period of 2024 through 2030.
Europe market for DNA Synthesis was valued at $ 311.8 million in 2023 and will reach $686 million by 2030, at a CAGR of 12.2% during the forecast period of 2024 through 2030.

The global key companies of DNA Synthesis include Genescript, Thermo Fisher Scientific, IDT, Twist Bioscience, BBI, Eurofins Genomics, DNA 2.0 (ATUM), OriGene, Eurogentec, etc. In 2023, the global five largest players hold a share approximately 53.36% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for DNA Synthesis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of DNA Synthesis by region & country, by Type, and by Application.
The DNA Synthesis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Synthesis.

Market Segmentation
By Company
Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec

Segment by Type
Oligonucleotide Synthesis
Gene Synthesis

Segment by Application
Commercial
Academic Research

By Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Rest of Asia-Pacific

Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe

South America
Brazil
Rest of South America

Middle East & Africa
Middle East
Africa


Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of DNA Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of DNA Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of DNA Synthesis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.



ページTOPに戻る


Table of Contents

1 Market Overview 1
1.1 DNA Synthesis Product Introduction 1
1.2 Global DNA Synthesis Market Size Forecast (2019-2030) 1
1.3 DNA Synthesis Market Trends & Drivers 3
1.3.1 DNA Synthesis Industry Trends 3
1.3.2 DNA Synthesis Market Drivers & Opportunity 5
1.3.3 DNA Synthesis Market Challenges 6
1.3.4 DNA Synthesis Market Restraints 7
1.4 Assumptions and Limitations 7
1.5 Study Objectives 8
1.6 Years Considered 9
2 Competitive Analysis by Company 10
2.1 Global DNA Synthesis Players Revenue Ranking (2023) 10
2.2 Global DNA Synthesis Revenue by Company (2019-2024) 11
2.3 Key Companies DNA Synthesis Area Served and Headquarters 12
2.4 Key Companies DNA Synthesis Product Offered 13
2.5 Key Companies Time to Begin Mass Production of DNA Synthesis 14
2.6 DNA Synthesis Market Competitive Analysis 15
2.6.1 DNA Synthesis Market Concentration Rate (2019-2024) 15
2.6.2 Global 5 and 10 Largest Companies by DNA Synthesis Revenue in 2023 16
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Synthesis as of 2023) 17
2.7 Mergers & Acquisitions, Expansion 18
3 Segmentation by Type 21
3.1 Introduction by Type 21
3.1.1 Oligonucleotide Synthesis 21
3.1.2 Gene Synthesis 22
3.2 Global DNA Synthesis Sales Value by Type 22
3.2.1 Global DNA Synthesis Sales Value by Type (2019 VS 2023 VS 2030) 23
3.2.2 Global DNA Synthesis Sales Value, by Type (2019-2030) 24
3.2.3 Global DNA Synthesis Sales Value, by Type (%) (2019-2030) 25
4 Segmentation by Application 26
4.1 Introduction by Application 26
4.1.1 Commercial 26
4.1.2 Academic Research 26
4.2 Global DNA Synthesis Sales Value by Application 27
4.2.1 Global DNA Synthesis Sales Value by Application (2019 VS 2023 VS 2030) 28
4.2.2 Global DNA Synthesis Sales Value, by Application (2019-2030) 29
4.2.3 Global DNA Synthesis Sales Value, by Application (%) (2019-2030) 30
5 Segmentation by Region 31
5.1 Global DNA Synthesis Sales Value by Region 31
5.1.1 Global DNA Synthesis Sales Value by Region: 2019 VS 2023 VS 2030 31
5.1.2 Global DNA Synthesis Sales Value by Region (2019-2024) 31
5.1.3 Global DNA Synthesis Sales Value by Region (2025-2030) 32
5.1.4 Global DNA Synthesis Sales Value by Region (%), (2019-2030) 32
5.2 North America 33
5.2.1 North America DNA Synthesis Sales Value, 2019-2030 33
5.2.2 North America DNA Synthesis Sales Value by Country (%), 2023 VS 2030 34
5.3 Europe 35
5.3.1 Europe DNA Synthesis Sales Value, 2019-2030 35
5.3.2 Europe DNA Synthesis Sales Value by Country (%), 2023 VS 2030 36
5.4 Asia Pacific 37
5.4.1 Asia Pacific DNA Synthesis Sales Value, 2019-2030 37
5.4.2 Asia Pacific DNA Synthesis Sales Value by Region (%), 2023 VS 2030 38
5.5 South America 39
5.5.1 South America DNA Synthesis Sales Value, 2019-2030 39
5.5.2 South America DNA Synthesis Sales Value by Country (%), 2023 VS 2030 40
5.6 Middle East & Africa 41
5.6.1 Middle East & Africa DNA Synthesis Sales Value, 2019-2030 41
5.6.2 Middle East & Africa DNA Synthesis Sales Value by Country (%), 2023 VS 2030 42
6 Segmentation by Key Countries/Regions 43
6.1 Key Countries/Regions DNA Synthesis Sales Value Growth Trends, 2019 VS 2023 VS 2030 43
6.2 Key Countries/Regions DNA Synthesis Sales Value, 2019-2030 44
6.3 North America 47
6.3.1 North America DNA Synthesis Sales Value, 2019-2030 47
6.3.2 North America DNA Synthesis Sales Value by Type (%), 2023 VS 2030 48
6.3.3 North America DNA Synthesis Sales Value by Application, 2023 VS 2030 48
6.4 Europe 49
6.4.1 Europe DNA Synthesis Sales Value, 2019-2030 49
6.4.2 Europe DNA Synthesis Sales Value by Type (%), 2023 VS 2030 50
6.4.3 Europe DNA Synthesis Sales Value by Application, 2023 VS 2030 50
6.5 Asia-Pacific 51
6.5.1 Asia-Pacific DNA Synthesis Sales Value, 2019-2030 51
6.5.2 Asia-Pacific DNA Synthesis Sales Value by Type (%), 2023 VS 2030 52
6.5.3 Asia-Pacific DNA Synthesis Sales Value by Application, 2023 VS 2030 52
6.6 South America 53
6.6.1 South America DNA Synthesis Sales Value, 2019-2030 53
6.6.2 South America DNA Synthesis Sales Value by Type (%), 2023 VS 2030 54
6.6.3 South America DNA Synthesis Sales Value by Application, 2023 VS 2030 54
6.7 Middle East and Africa 55
6.7.1 Middle East and Africa DNA Synthesis Sales Value, 2019-2030 55
6.7.2 Middle East and Africa DNA Synthesis Sales Value by Type (%), 2023 VS 2030 56
6.7.3 Middle East and Africa DNA Synthesis Sales Value by Application, 2023 VS 2030 56
7 Company Profiles 57
7.1 GenScript Biotech 57
7.1.1 GenScript Biotech Profile 57
7.1.2 GenScript Biotech Main Business 58
7.1.3 GenScript Biotech DNA Synthesis Products, Services and Solutions 58
7.1.4 GenScript Biotech DNA Synthesis Revenue (US$ Million) & (2019-2024) 60
7.1.5 GenScript Biotech Recent Developments 60
7.2 Thermo Fisher Scientific 61
7.2.1 Thermo Fisher Scientific Profile 61
7.2.2 Thermo Fisher Scientific Main Business 62
7.2.3 Thermo Fisher Scientific DNA Synthesis Products, Services and Solutions 62
7.2.4 Thermo Fisher Scientific DNA Synthesis Revenue (US$ Million) & (2019-2024) 64
7.2.5 Thermo Fisher Scientific Recent Developments 64
7.3 IDT 65
7.3.1 IDT Profile 65
7.3.2 IDT Main Business 66
7.3.3 IDT DNA Synthesis Products, Services and Solutions 67
7.3.4 IDT DNA Synthesis Revenue (US$ Million) & (2019-2024) 67
7.3.5 IDT Recent Developments 68
7.4 Eurofins Scientific 69
7.4.1 Eurofins Scientific Profile 69
7.4.2 Eurofins Scientific Main Business 70
7.4.3 Eurofins Scientific DNA Synthesis Products, Services and Solutions 70
7.4.4 Eurofins Scientific DNA Synthesis Revenue (US$ Million) & (2019-2024) 72
7.4.5 Eurofins Scientific Recent Developments 73
7.5 DNA 2.0 (ATUM) 73
7.5.1 DNA 2.0 (ATUM) Profile 73
7.5.2 DNA 2.0 (ATUM) Main Business 74
7.5.3 DNA 2.0 (ATUM) DNA Synthesis Products, Services and Solutions 74
7.5.4 DNA 2.0 (ATUM) DNA Synthesis Revenue (US$ Million) & (2019-2024) 75
7.6 BBI 76
7.6.1 BBI Profile 76
7.6.2 BBI Main Business 76
7.6.3 BBI DNA Synthesis Products, Services and Solutions 77
7.6.4 BBI DNA Synthesis Revenue (US$ Million) & (2019-2024) 78
7.6.5 BBI Recent Developments 79
7.7 Azenta Life Sciences 79
7.7.1 Azenta Life Sciences Profile 79
7.7.2 Azenta Life Sciences Main Business 80
7.7.3 Azenta Life Sciences DNA Synthesis Products, Services and Solutions 81
7.7.4 Azenta Life Sciences DNA Synthesis Revenue (US$ Million) & (2019-2024) 82
7.7.5 Azenta Life Sciences Recent Developments 82
7.8 SBS Genetech 83
7.8.1 SBS Genetech Profile 83
7.8.2 SBS Genetech Main Business 84
7.8.3 SBS Genetech DNA Synthesis Products, Services and Solutions 85
7.8.4 SBS Genetech DNA Synthesis Revenue (US$ Million) & (2019-2024) 86
7.9 Bio Basic 86
7.9.1 Bio Basic Profile 86
7.9.2 Bio Basic Main Business 87
7.9.3 Bio Basic DNA Synthesis Products, Services and Solutions 87
7.9.4 Bio Basic DNA Synthesis Revenue (US$ Million) & (2019-2024) 88
7.10 Twist Bioscience 88
7.10.1 Twist Bioscience Profile 88
7.10.2 Twist Bioscience Main Business 89
7.10.3 Twist Bioscience DNA Synthesis Products, Services and Solutions 89
7.10.4 Twist Bioscience DNA Synthesis Revenue (US$ Million) & (2019-2024) 90
7.10.5 Twist Bioscience Recent Developments 90
7.11 OriGene 91
7.11.1 OriGene Profile 91
7.11.2 OriGene Main Business 92
7.11.3 OriGene DNA Synthesis Products, Services and Solutions 93
7.11.4 OriGene DNA Synthesis Revenue (US$ Million) & (2019-2024) 93
7.12 Bioneer 93
7.12.1 Bioneer Profile 93
7.12.2 Bioneer Main Business 94
7.12.3 Bioneer DNA Synthesis Products, Services and Solutions 95
7.12.4 Bioneer DNA Synthesis Revenue (US$ Million) & (2019-2024) 95
7.13 Eton Bioscience 96
7.13.1 Eton Bioscience Profile 96
7.13.2 Eton Bioscience Main Business 96
7.13.3 Eton Bioscience DNA Synthesis Products, Services and Solutions 97
7.13.4 Eton Bioscience DNA Synthesis Revenue (US$ Million) & (2019-2024) 98
7.14 Synbio Technologies 98
7.14.1 Synbio Technologies Profile 98
7.14.2 Synbio Technologies Main Business 99
7.14.3 Synbio Technologies DNA Synthesis Products, Services and Solutions 100
7.14.4 Synbio Technologies DNA Synthesis Revenue (US$ Million) & (2019-2024) 100
7.15 Eurogentec 101
7.15.1 Eurogentec Profile 101
7.15.2 Eurogentec Main Business 101
7.15.3 Eurogentec DNA Synthesis Products, Services and Solutions 102
7.15.4 Eurogentec DNA Synthesis Revenue (US$ Million) & (2019-2024) 103
8 Industry Chain Analysis 104
8.1 DNA Synthesis Industrial Chain 104
8.2 DNA Synthesis Upstream Analysis 105
8.2.1 Key Raw Materials 105
8.2.2 Raw Materials Key Suppliers 105
8.2.3 Manufacturing Cost Structure 106
8.3 Downstream Analysis (Customers Analysis) 107
8.4 Sales Model and Sales Channels 109
8.4.1 DNA Synthesis Sales Model 109
8.4.2 Sales Channel 109
8.4.3 DNA Synthesis Distributors 110
9 Research Findings and Conclusion 113
10 Appendix 115
10.1 Research Methodology 115
10.1.1 Methodology/Research Approach 115
10.1.2 Data Source 118
10.2 Author Details 121
10.3 Disclaimer 121


 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/05 10:26

162.17 円

175.82 円

209.73 円

ページTOPに戻る